Literature DB >> 27535273

[The regional network ADAPTHERA : Rheumatology care through coordinated cooperation: comprehensive, trans-sectoral, covering all health insurance. Initial results].

A Schwarting1,2, B Pfeiff3, C Amberger4, D Pick4, M Hesse5, M Jendro6, J Engels7, A Böttger8, C Kuhn9, J Majdandzic10, W Ziese11, M-L Stadelmann12, F W Kessler13, H Dinges14, S Ultes-Kaiser15, U Droste16, M Schmalhofer16, A Hazenbiller17, M Rector3, J Weinmann-Menke17, K Triantafyllias3, M Becker17, M Ataian18, M Lablans18, F Ueckert18, T Panholzer19, M Blettner19.   

Abstract

The aim of the rheumatology network ADAPTHERA ("risk-adapted rheumatology therapy") is to achieve a comprehensive improvement in rheumatology care by coordinating treatment in a regional, trans-sectoral network. Accompanying biomedical research projects, training concepts, and the construction of a rheumatology register (gathering data and biomaterials) should furthermore ensure the stable and sustainable optimisation of care. In the pilot phase (2012-2015) the focus of the ADAPTHERA network, required as a "regional key project" within the framework of the Initiative on Health Economy of Rheinland-Palatinate (RL-P), Germany, was placed on the optimisation of the early diagnosis of rheumatoid arthritis, where it is well-known that there is a significant care deficit.Through the intensive, stable, and coordinated cooperation of all health care partners in the field of rheumatology (registered general practitioners and orthopaedic specialists, registered core rheumatologists as well as the Association of Rheumatology of RL-P) a unique regional, comprehensive offer with verifiable care optimisation has been established in RL-P. The network is supported by outstanding collaboration with the Association of Statutory Health Insurance Physicians and the self-help organisation Rheumatology League.The aims that were established at the start of the project will be achieved by the end of the pilot phase:- significant improvement in the early diagnosis of rheumatoid arthritis (an average of 23.7 days until diagnosis by rheumatologists)- access covering all health insurance (regardless of the particular scheme the patients belong to)- comprehensive (verifiable participation of general practitioners from all over RL-P)- data and biomaterials collection, established as a basis for biomarker research, and a rheumatology register for RL-P.

Entities:  

Keywords:  Coordinated treatment; Early diagnosis; Rheumatology care; Rheumatology network; Rheumatology register

Mesh:

Year:  2016        PMID: 27535273     DOI: 10.1007/s00393-016-0132-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  6 in total

1.  Long-term impact of delay in assessment of patients with early arthritis.

Authors:  Michael P M van der Linden; Saskia le Cessie; Karim Raza; Diane van der Woude; Rachel Knevel; Tom W J Huizinga; Annette H M van der Helm-van Mil
Journal:  Arthritis Rheum       Date:  2010-12

2.  [Diagnostic spectrum, treatment indication and symptom duration in initial referrals to the rheumatologist].

Authors:  G Westhoff; E Edelmann; J Kekow; A Zink
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

Review 3.  Early rheumatoid arthritis -- is there a window of opportunity?

Authors:  John J Cush
Journal:  J Rheumatol Suppl       Date:  2007-11

Review 4.  Rheumatoid arthritis--early diagnosis and disease management.

Authors:  Matthias Schneider; Klaus Krüger
Journal:  Dtsch Arztebl Int       Date:  2013-07-08       Impact factor: 5.594

5.  Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.

Authors:  D Huscher; S Merkesdal; K Thiele; H Zeidler; M Schneider; A Zink
Journal:  Ann Rheum Dis       Date:  2006-03-15       Impact factor: 19.103

Review 6.  Early arthritis therapy: rationale and current approach.

Authors:  K P Machold; G Eberl; B F Leeb; V Nell; B Windisch; J S Smolen
Journal:  J Rheumatol Suppl       Date:  1998-07
  6 in total
  2 in total

Review 1.  [Experiences and results from Rheuma-VOR].

Authors:  A Schwarting; M Dreher; G Assmann; T Witte; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

2.  Work situation of rheumatologists and residents in times of COVID-19 : Findings from a survey in Germany.

Authors:  Ellen Kuhlmann; Luzia Bruns; Kirsten Hoeper; Marianne Richter; Torsten Witte; Diana Ernst; Alexandra Jablonka
Journal:  Z Rheumatol       Date:  2021-09-17       Impact factor: 1.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.